These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34374466)

  • 1. "This is part of emergency medicine now": A qualitative assessment of emergency clinicians' facilitators of and barriers to initiating buprenorphine.
    Schoenfeld EM; Soares WE; Schaeffer EM; Gitlin J; Burke K; Westafer LM
    Acad Emerg Med; 2022 Jan; 29(1):28-40. PubMed ID: 34374466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of Buprenorphine in the Emergency Department: A Survey of Emergency Clinicians.
    Barkley A; Lander L; Dilcher B; Tuscano M
    West J Emerg Med; 2024 Jul; 25(4):470-476. PubMed ID: 39028232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals.
    Patel E; Solomon K; Saleem H; Saloner B; Pugh T; Hulsey E; Leontsini E
    J Subst Abuse Treat; 2022 May; 136():108658. PubMed ID: 34774397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine.
    Hawk KF; D'Onofrio G; Chawarski MC; O'Connor PG; Cowan E; Lyons MS; Richardson L; Rothman RE; Whiteside LK; Owens PH; Martel SH; Coupet E; Pantalon M; Curry L; Fiellin DA; Edelman EJ
    JAMA Netw Open; 2020 May; 3(5):e204561. PubMed ID: 32391893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department.
    Wiercigroch D; Hoyeck P; Sheikh H; Hulme J
    BMC Emerg Med; 2021 Apr; 21(1):48. PubMed ID: 33858328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Just give them a choice": Patients' perspectives on starting medications for opioid use disorder in the ED.
    Schoenfeld EM; Westafer LM; Beck SA; Potee BG; Vysetty S; Simon C; Tozloski JM; Girardin AL; Soares WE
    Acad Emerg Med; 2022 Aug; 29(8):928-943. PubMed ID: 35426962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers and facilitators associated with establishment of emergency department-initiated buprenorphine for opioid use disorder in rural Maine.
    Rosenberg NK; Hill AB; Johnsky L; Wiegn D; Merchant RC
    J Rural Health; 2022 Jun; 38(3):612-619. PubMed ID: 34468047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician attitudes on buprenorphine induction in the emergency department: results from a multistate survey.
    Zuckerman M; Kelly T; Heard K; Zosel A; Marlin M; Hoppe J
    Clin Toxicol (Phila); 2021 Apr; 59(4):279-285. PubMed ID: 32870039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department-Initiated Buprenorphine Programs.
    Sue KL; Chawarski M; Curry L; McNeil R; Coupet E; Schwartz RP; Wilder C; Tsui JI; Hawk KF; D'Onofrio G; O'Connor PG; Fiellin DA; Edelman EJ
    JAMA Netw Open; 2023 May; 6(5):e2312718. PubMed ID: 37163263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency department interventions for opioid use disorder: A synthesis of emerging models.
    Thomas CP; Stewart MT; Tschampl C; Sennaar K; Schwartz D; Dey J
    J Subst Abuse Treat; 2022 Oct; 141():108837. PubMed ID: 35841743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on and experiences of emergency department-initiated buprenorphine among clinical pharmacists: A multi-site qualitative study.
    Justen M; Edelman EJ; Chawarski M; Coupet E; Cowan E; Lyons M; Owens P; Martel S; Richardson L; Rothman R; Whiteside L; O'Connor PG; Zahn E; D'Onofrio G; Fiellin DA; Hawk KF
    J Subst Use Addict Treat; 2023 Dec; 155():209058. PubMed ID: 37149149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency Department Clinicians' Attitudes Toward Opioid Use Disorder and Emergency Department-initiated Buprenorphine Treatment: A Mixed-Methods Study.
    Im DD; Chary A; Condella AL; Vongsachang H; Carlson LC; Vogel L; Martin A; Kunzler N; Weiner SG; Samuels-Kalow M
    West J Emerg Med; 2020 Feb; 21(2):261-271. PubMed ID: 32191184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments.
    Sasson C; Dieujuste N; Klocko R; Basrai Z; Celedon M; Hsiao J; Himstreet J; Hoffman J; Pfaff C; Malmstrom R; Smith J; Holstein A; Johnson-Koenke R
    Acad Emerg Med; 2023 Apr; 30(4):289-298. PubMed ID: 36757683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver.
    Lanham HJ; Papac J; Olmos DI; Heydemann EL; Simonetti N; Schmidt S; Potter JS
    JAMA Netw Open; 2022 May; 5(5):e2212419. PubMed ID: 35552721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative assessment of emergency physicians' experiences with robust emergency department buprenorphine bridge programs.
    Heil JM; Lassiter JM; Salzman MS; Herring A; Hoppe J; Lynch M; Weiner SG; Roberts B; Haroz R
    Acad Emerg Med; 2024 Jun; 31(6):576-583. PubMed ID: 38357749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A State Financial Incentive Policy to Improve Emergency Department Treatment for Opioid Use Disorder: A Qualitative Study.
    Kilaru AS; Lubitz SF; Davis J; Eriksen W; Siegel S; Kelley D; Perrone J; Meisel ZF
    Psychiatr Serv; 2021 Sep; 72(9):1048-1056. PubMed ID: 33593105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and Facilitators to the Outpatient Management of Low-risk Pulmonary Embolism From the Emergency Department.
    Westafer LM; Jessen E; Zampi M; Boccio E; Casey SD; Lindenauer PK; Vinson DR
    Ann Emerg Med; 2023 Sep; 82(3):381-393. PubMed ID: 37596016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitators of and barriers to buprenorphine initiation for people with opioid use disorder in the emergency department: protocol for a scoping review.
    Bozinoff N; Soobiah C; Rodak T; Bucago C; Kingston K; Klaiman M; Poynter B; Samuels G; Schoenfeld E; Shelton D; Kalocsai C
    BMJ Open; 2021 Sep; 11(9):e053207. PubMed ID: 34580102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation strategies to address the determinants of adoption, implementation, and maintenance of a clinical decision support tool for emergency department buprenorphine initiation: a qualitative study.
    Simpson MJ; Ritger C; Hoppe JA; Holland WC; Morris MA; Nath B; Melnick ER; Tietbohl C
    Implement Sci Commun; 2023 Apr; 4(1):41. PubMed ID: 37081581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and Facilitators to the Use of Medications for Opioid Use Disorder: a Rapid Review.
    Mackey K; Veazie S; Anderson J; Bourne D; Peterson K
    J Gen Intern Med; 2020 Dec; 35(Suppl 3):954-963. PubMed ID: 33145687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.